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The authors reply: We have carefully read and
considered the letter from Prof. Miller and Dr.
Brealey,1 distinguished experts of electron micro-
scopy (EM), and appreciate that they pointed out
the limitations of our study.2
We agree with Miller and Brealey’s point and recognize
that there are inherent difficulties in discrimination of
cellular vesicles from viral particles solely by morpholog-
ical evidence, especially in routine EM processing of au-
topsy tissues. These conditions differ markedly from the
in vitro negative staining of body fluids or cell culture,
which are the techniques usually utilized for optimal
visualization of viral structure. However, EM is still an
essential tool and a front-line evaluation method in the
search for unknown pathogens in outbreaks or epidemics.
For example, the causative agents of the outbreak of severe
acute respiratory syndrome (SARS) in China in 2003 and
human monkey pox in the United States in 2003 were
both first identified by EM. In addition, with our
immunofluorescence staining for SARS-coronavirus (CoV)
nuclear protein as we presented in our paper (Figure 3d)2
and the recent publications of ultrastructural feature of
SARS-CoV-2,3,4 we consider the structures as possible, but
not definitively proven, CoV. We have therefore prudently
changed the description in the preprint version of our
article of “viral particle” to “coronavirus-like particle.”
Ideally, immuno-EM or in situ hybridization studies to
assess local protein or RNA levels of CoV will further
clarify the possibility of direct kidney parenchymal infec-
tion. Such a combination of ultrastructural images and
molecular data could then definitively identify viral-like
particles as SARS-CoV-2.
1. Miller SE, Brealey JK. Visualization of putative coronavirus in kidney. Kidney
Int. 2020;98:231–232.
l e t t e r s to the ed i to rThe authors reply: We thank Drs. Miller and
Brealey1 for their comments and fully acknowledge
their expertise in the field of electron microscopy.
We also acknowledge our uncertainties regarding
the exact nature of the particles seen in the podocytes in our
patient’s kidney biopsy, and we were cautious in the inter-
pretation of these findings. Following Drs. Miller and Brea-
ley’s comments,1 we have modified our letter before its final
publication in the journal to further underline that these
particles may correspond to nonviral entities.
However, the particles detected in our patient’s biopsy are
rather similar to the ones reported in the first documentation of
severe acute respiratory syndrome coronavirus 2.2 Besides, the
appearance of intracellular viral inclusions appears to be quite
variable from one publication to another.3,4 To our opinion, it
remains, therefore, possible that the particles observed in our
patient are of viral origin.Nevertheless, we totally agreewithDrs.
Miller and Brealey1 that the definite proof for the presence of
viral inclusions in cells requires an immunostainingwith specific
antibodies, whether in cultured cells or in tissue samples.
Our knowledge of coronavirus disease 2019 is rapidly
evolving and caution is of the utmost importance.2321. Miller SE, Brealey JK. Visualiziation of putative coronavirus in kidney. Kidney
Int. 2020;98:231–232.
2. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with
pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
3. Su H, Yang M, Wan C, et al. Renal histopathological analysis of 26
postmortem findings of patients with COVID-19 in China. Kidney Int.
2020;98:219–227.
4. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and
endotheliitis in COVID-19. Lancet. 2020;395:1417–1418.
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